Spravato (Esketamine)
- Home
- Spravato (Esketamine)
Divine Soul Mental Health
We are a Certified Spravato (Esketamine) Treatment Center
SPRAVATO™ (Esketamine) – New FDA approved treatment for Treatment-Resistant Depression
SPRAVATO® (esketamine) CIII Nasal Spray is indicated, in conjunction with an oral antidepressant, for the treatment of:
- Treatment-resistant depression (TRD) in adults.
- Depressive symptoms in adults with major depressive disorder (MDD) with acute suicidal ideation or behavior